Close
  • Latest News
  • Cybersecurity
  • Big Data and Analytics
  • Cloud
  • Mobile
  • Networking
  • Storage
  • Applications
  • IT Management
  • Small Business
  • Development
  • Database
  • Servers
  • Android
  • Apple
  • Innovation
  • Blogs
  • PC Hardware
  • Reviews
  • Search Engines
  • Virtualization
Read Down
Sign in
Close
Welcome!Log into your account
Forgot your password?
Read Down
Password recovery
Recover your password
Close
Search
Menu
Search
  • Latest News
  • Cybersecurity
  • Big Data and Analytics
  • Cloud
  • Mobile
  • Networking
  • Storage
  • Applications
  • IT Management
  • Small Business
  • Development
  • Database
  • Servers
  • Android
  • Apple
  • Innovation
  • Blogs
  • PC Hardware
  • Reviews
  • Search Engines
  • Virtualization
More
    Home Applications
    • Applications

    IPO for Clinical Trial Software Provider

    By
    Stacy Lawrence
    -
    April 1, 2004
    Share
    Facebook
    Twitter
    Linkedin

      Phase Forward, a startup provider of data management software tools for clinical trials, filed for an $86 million initial public offering on March 15. Other than Oracle Corp., Phase Forward is one of the only enterprise software competitors with a solution for the management of clinical trials data.

      /zimages/4/28571.gifClick here to read more about Oracles clinical trial software.

      So far, life sciences companies have been slow to adopt any form of electronic data capture (EDC) software. Technology market research firm Forrester Research Inc. estimates that in 2002, 97 percent of clinical trial data was collected on paper. In that year only 8 percent of clinical trials used EDC software. But by 2006, Forrester is expecting that proportion to have grown to one-third.

      Even with this reluctance, Phase Forwards products are proving relatively popular. The company has more than 300 customers, including 11 out of the 15 major pharmaceutical companies. In November, Eli Lilly and Co. signed a deal to expand its commitment from Phase Forwards electronic data capture solution, InForm, to include its Clintrial clinical data management system as well. According to the press release put out at the time, Eli Lilly hopes that by managing its data more effectively it will increase the flexibility and scalability of its global clinical trial research efforts.

      In combination, InForm and Clintrial form a clinical trial data management environment that handles collection, consolidation, analysis, reporting, and preparation for submission and archiving. This integration then allows adverse events noted during the collection of clinical trial data to be automatically routed to another Phase Forward product, Clintrace, a safety reporting and tracking system.

      Software licenses and application hosting services each comprised about a third of the companys revenue last year, with the remainder coming from customer support and consulting services. On revenues of $62 million, Phase Forward lost $6.7 million in 2003. Revenue was up only 3 percent over the year before. Customers based in North America account for slightly more than two-thirds of its revenue, with European companies representing 30 percent and Asia the remaining 5 percent.

      Although the company was briefly profitable in the third quarter of last year, company officials dont expect consistent profitability in the near-term. Phase Forward is devoting considerable resources to integrating all three of its software systems onto a Microsoft-based platform that will run on an Oracle database.

      Since its inception in 1997, the company has garnered about $72 million in venture capital investment. Its largest investors – and shareholders – are Atlas Venture which holds 17.5 percent of outstanding shares, North Bridge Venture Partners with 17.4 percent and Thomas Weisel with 10.3 percent.

      Avatar
      Stacy Lawrence
      Stacy Lawrence is co-editor of CIOInsight.com's Health Care Center. Lawrence has covered IT and the life sciences for various publications, including Business 2.0, Red Herring, The Industry Standard and Nature Biotechnology. Before becoming a journalist, Lawrence attended New York University and continued on in the sociology doctoral program at UC Berkeley.

      MOST POPULAR ARTICLES

      Android

      Samsung Galaxy XCover Pro: Durability for Tough...

      Chris Preimesberger - December 5, 2020 0
      Have you ever dropped your phone, winced and felt the pain as it hit the sidewalk? Either the screen splintered like a windshield being...
      Read more
      Cloud

      Why Data Security Will Face Even Harsher...

      Chris Preimesberger - December 1, 2020 0
      Who would know more about details of the hacking process than an actual former career hacker? And who wants to understand all they can...
      Read more
      Cybersecurity

      How Veritas Is Shining a Light Into...

      eWEEK EDITORS - September 25, 2020 0
      Protecting data has always been one of the most important tasks in all of IT, yet as more companies become data companies at the...
      Read more
      Big Data and Analytics

      How NVIDIA A100 Station Brings Data Center...

      Zeus Kerravala - November 18, 2020 0
      There’s little debate that graphics processor unit manufacturer NVIDIA is the de facto standard when it comes to providing silicon to power machine learning...
      Read more
      Apple

      Why iPhone 12 Pro Makes Sense for...

      Wayne Rash - November 26, 2020 0
      If you’ve been watching the Apple commercials for the past three weeks, you already know what the company thinks will happen if you buy...
      Read more
      eWeek


      Contact Us | About | Sitemap

      Facebook
      Linkedin
      RSS
      Twitter
      Youtube

      Property of TechnologyAdvice.
      Terms of Service | Privacy Notice | Advertise | California - Do Not Sell My Information

      © 2021 TechnologyAdvice. All Rights Reserved

      Advertiser Disclosure: Some of the products that appear on this site are from companies from which TechnologyAdvice receives compensation. This compensation may impact how and where products appear on this site including, for example, the order in which they appear. TechnologyAdvice does not include all companies or all types of products available in the marketplace.

      ×